1. Home
  2. ME vs ALCY Comparison

ME vs ALCY Comparison

Compare ME & ALCY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ME
  • ALCY
  • Stock Information
  • Founded
  • ME 2006
  • ALCY 2021
  • Country
  • ME United States
  • ALCY United States
  • Employees
  • ME N/A
  • ALCY N/A
  • Industry
  • ME Precision Instruments
  • ALCY Blank Checks
  • Sector
  • ME Health Care
  • ALCY Finance
  • Exchange
  • ME Nasdaq
  • ALCY Nasdaq
  • Market Cap
  • ME 98.7M
  • ALCY N/A
  • IPO Year
  • ME N/A
  • ALCY 2023
  • Fundamental
  • Price
  • ME $3.39
  • ALCY $11.05
  • Analyst Decision
  • ME Hold
  • ALCY
  • Analyst Count
  • ME 1
  • ALCY 0
  • Target Price
  • ME $9.40
  • ALCY N/A
  • AVG Volume (30 Days)
  • ME 219.4K
  • ALCY 367.0
  • Earning Date
  • ME 02-05-2025
  • ALCY 01-01-0001
  • Dividend Yield
  • ME N/A
  • ALCY N/A
  • EPS Growth
  • ME N/A
  • ALCY 179.15
  • EPS
  • ME N/A
  • ALCY 0.37
  • Revenue
  • ME $193,260,000.00
  • ALCY N/A
  • Revenue This Year
  • ME $21.93
  • ALCY N/A
  • Revenue Next Year
  • ME $17.31
  • ALCY N/A
  • P/E Ratio
  • ME N/A
  • ALCY $29.86
  • Revenue Growth
  • ME N/A
  • ALCY N/A
  • 52 Week Low
  • ME $2.66
  • ALCY $10.48
  • 52 Week High
  • ME $16.52
  • ALCY $13.14
  • Technical
  • Relative Strength Index (RSI)
  • ME 44.56
  • ALCY 56.44
  • Support Level
  • ME $3.15
  • ALCY $11.01
  • Resistance Level
  • ME $4.18
  • ALCY $10.98
  • Average True Range (ATR)
  • ME 0.26
  • ALCY 0.00
  • MACD
  • ME 0.05
  • ALCY 0.02
  • Stochastic Oscillator
  • ME 29.46
  • ALCY 100.00

About ME 23andMe Holding Co.

23andMe Holding Co is a consumer-facing healthcare technology company, primarily involved in the sale of direct-to-consumer personal genome services, or PGS, through DNA collection kits shipped via mail. The company provides users access to reports summarizing estimated genetic ancestry breakdown, phenotypic trait reports, and various health predisposition and disease carrier reports. Its segment includes Consumer and Research Services and Therapeutics. The company generates maximum revenue from the Consumer and Research Services segment.

About ALCY Alchemy Investments Acquisition Corp 1

Alchemy Investments Acquisition Corp 1 is a blank check company.

Share on Social Networks: